Professional Documents
Culture Documents
Immunology Q&A
1. De ne MHC restriction.
Answer: MHC restriction means that the T lymphocytes are only able to recognize peptides of
antigens when these peptides are on the MHC molecules.
5. What is CCR7?
Answer: CCR7 is a receptor which is expressed on the dendritic cells after activation. CCR7 is
attracted to chemokines that are produced by lymphoid tissue at the sites where are T lymphocytes
in the lymph nodes. This is important so that dendritic cells carry captured antigens to the T
lymphocytes.
6. What are the di erences between MHC class I and MHC class II?
Answer: There are several di erences between class I MHC and class II:
* Composed of three alpha domains and one * Composed of two alpha and two beta
beta domain. domains.
* Present antigens to cytotoxic T cells (CD8+). * Present antigens to the T helper cells (CD4+).
* In MHC class I, processing involves ubiquitin - proteasome pathway: intracellular antigen proteins
are unfolded, and covalently bound to ubiquitin, then taken to the proteasome, where we have
proteolytic enzymes and this enzymes turn proteins into peptides, so that these peptides can t
into the MHC class I molecule.
* In MHC class II, processing starts with phagocytosis of the extracellular proteins. Then these
proteins are in the APCs and degraded to the peptides by lysosomal enzymes.
1
fi
ff
ff
ff
fi
Tuesday, 4 October 2022
10. How are peptides bound to the MHC molecules?
Answer: This process is somewhat di erent for both MHC class molecules:
* MHC class I are always produced in the ER, whereas the peptides are in the cytosol, to solve this
problem, TAP bind the peptides and pumps into the ER. New MHCs bind to a protein tapasin,
which binds MHC I to TAP and MHC I easily binds to the peptides which were brought by TAP.
* MHC class II are also always produced in the ER of APCs. Each new MHC II carries invariant
protein, which is bound to the peptide binding cleft of the MHC II molecule. MHC class II go from
the ER to the Golgi clefts and then to the endosomes where the proteins are being degraded into
peptides. Here we have MHC II-like molecule called the MD, which takes the invariant protein and
frees the peptide binding cleft of MHC, so the MHC II is able to bind the peptide.
* Phagocytosis by APCs
2
ff